Papillomavirus-like particle vaccines for cervical cancer (Q33632759)

28 July 2017

1 reference

title

Papillomavirus-like particle vaccines for cervical cancer (English)

1 reference

28 July 2017

cervix uterine cancer

1 reference

Schiller JT

1

1 reference

28 July 2017

1 May 1999

1 reference

Trends in Molecular Medicine

28 July 2017

1 reference

28 July 2017

5

1 reference

28 July 2017

5

1 reference

28 July 2017

209-215

1 reference

Is vaccination against human papillomavirus a possibility?

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Chimeric papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

In vitro gene transfer using human papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901463-X

7 January 2021

10.1016/S1357-4310(99)01463-X

Identifiers

DOI

1 reference

release_4xbeiaf7dncdlebeyqlthxk4ee

28 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4xbeiaf7dncdlebeyqlthxk4ee

24 November 2022

mapped directly with Wikidata item

PubMed ID

10322313

1 reference

PubMed ID

10322313